Product Center
Product Center

With electronic materials as the core, while also focusing on the development of highly challenging pharmaceutical intermediates.

Pharmaceutical intermediate

The company maintains and concurrently advances its CRO/CDMO business for clinically challenging drug intermediates, as well as ADC drug development, thereby establishing a dual‑technology support framework spanning electronic materials and pharmaceutical chemistry.